Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, The Lancet, 10303(398), p. 856-869, 2021

DOI: 10.1016/s0140-6736(21)01694-9

Links

Tools

Export citation

Search in Google Scholar

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Journal article published in 2021 by Xinxue Liu, Robert H. Shaw, Arabella S. V. Stuart, Melanie Greenland, Parvinder K. Aley, Nick J. Andrews, J. Claire Cameron, Sue Charlton, Elizabeth A. Clutterbuck, Andrea M. Collins, Tanya Dinesh, Anna England, Saul N. Faust, Daniela M. Ferreira, Adam Finn and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO